RXRX
Rate Of Return$Recursion Pharmaceuticals(RXRX.US) Before the Phase 2 data conclusion for drug 4881 is released, any drop can be ignored. The life-or-death moment is right here.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments